Surgery Partners, Inc. (SGRY) Financial Statements (2023 and earlier)

Company Profile

Business Address 310 SEVEN SPRINGS WAY
BRENTWOOD, TN 37027
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8062 - General Medical and Surgical Hospitals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments283155227379390330465
Cash and cash equivalents283155227379390330465
Receivables456422412412430393375
Inventory, net of allowances, customer advances and progress billings71696463615957
Inventory71696463615957
Prepaid expense31363732263028
Other current assets79574851392928
Total current assets:921738788937946842953
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization530532460468330  
Operating lease, right-of-use asset279277278277324321319
Property, plant and equipment      (231)
Long-term investments and receivables19018916095899090
Long-term investments19018916095899090
Intangible assets, net (including goodwill), including:4,1794,1874,0363,9683,9563,6593,534
Goodwill4,1374,1453,9933,9263,9123,6143,488
Intangible assets, net (excluding goodwill)42   44  
Other undisclosed intangible assets, net (including goodwill) 414342 4646
Estimated insurance recoveries1399991111
Deferred income tax assets92103110114114128130
Other noncurrent assets144169131120595051
Other undisclosed noncurrent assets334333320303291532764
Total noncurrent assets:5,7615,7985,5035,3535,1724,7904,668
TOTAL ASSETS:6,6826,5376,2926,2906,1185,6325,621
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities221277294207202190185
Employee-related liabilities698484777376
Accounts payable152138126123125117109
Accrued liabilities696984    
Debt631176868606170
Other liabilities207292222221210208199
Other undisclosed current liabilities3(61)(62)47648279
Total current liabilities:493624522542537541532
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,5593,1033,0193,0252,8782,7922,786
Finance lease, liability565564482485346  
Other undisclosed long-term debt and lease obligation1,9942,2692,2662,2682,2172,4802,475
Liabilities, other than long-term debt34796969687124152
Other liabilities7596969687124152
Operating lease, liability271270272272316312311
Other undisclosed noncurrent liabilities 270272272316312311
Total noncurrent liabilities:2,9063,4683,3883,3933,2813,2293,249
Total liabilities:3,3994,0923,9093,9353,8183,7693,781
Temporary equity, carrying amount342339342342330310313
Equity
Equity, attributable to parent, including:1,9981,1731,1551,1611,089756765
Additional paid in capital2,4781,6231,6191,6251,6221,3061,298
Accumulated other comprehensive income (loss)76834425(32)(48)(54)
Accumulated deficit(557)(534)(509)(491)(503)(503)(480)
Other undisclosed equity, attributable to parent1111111
Equity, attributable to noncontrolling interest943933885852881796762
Total equity:2,9412,1052,0412,0131,9701,5521,527
TOTAL LIABILITIES AND EQUITY:6,6826,5376,2926,2906,1185,6325,621

Income Statement (P&L) ($ in millions)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Revenues707621615596610559543
Gross profit:707621615596610559543
Operating expenses(613)(547)(539)(496)(495)(496)(484)
Operating income:9474771001156460
Interest and debt expense(12)  (10)(9)1(10)
Other undisclosed income from continuing operations before equity method investments, income taxes    1  
Income from continuing operations before equity method investments, income taxes:827377911076450
Income from equity method investments 233333
Income from continuing operations before income taxes:827579941106753
Income tax expense (benefit)(10)(8)(4)(1)(12)(1)3
Income from continuing operations:72687592986556
Income before gain (loss) on sale of properties:687592986556
Other undisclosed net loss(49)(61)(60)(50)(56)(57)(47)
Net income:23615434389
Net loss attributable to noncontrolling interest(47)(31)(34)(31)(43)(31)(36)
Net income (loss) available to common stockholders, diluted:(23)(25)(18)12(0)(23)(27)

Comprehensive Income ($ in millions)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Net income:23615434389
Other undisclosed comprehensive income (loss)(7)3919571670
Comprehensive income:17443410059159
Comprehensive loss, net of tax, attributable to noncontrolling interest(47)(31)(34)(31)(43)(31)(36)
Comprehensive income (loss), net of tax, attributable to parent:(30)1416916(16)(27)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: